We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Cancer Immunology – Products

Drug molecules.
Product News

Reithera and Sillajen Partnership Announced

ReiThera is proud to announce a new partnership with SillaJen through a comprehensive Master Service Agreement (MSA), which establishes ReiThera as the manufacturing partner for SillaJen’s innovative anticancer virus platform, the SJ-600 series.
Immune checkpoint-related products for immuno-oncology therapy, featuring proteins, cell lines, and screening kits.
Product
Advertisement

Comprehensive Immune Checkpoint-Related Products for Immuno-Oncology Therapy

We offer a comprehensive suite of immune checkpoint-related products, including high-quality proteins, inhibitor screening kits, stable cell lines, and PK assay kits for quantitative analysis.
A Cell Imaging screen showcasing an array of bright hues and intricate designs.
App Note / Case Study

Uncovering the Role of T Cells in Cancer With Spatial Biology

This application focus explores how high-plex spatial profiling can be applied to better understand the role of T cells in cancer immune surveillance and how cancers evade the immune system.
3D illustration of bispecific antibodies in red and blue, showcasing their dual-targeting structure on a teal background.
Whitepaper

Revolutionizing Cancer Therapy With Bispecific Antibodies

This whitepaper discusses the classification of bsAbs targeting immunomodulatory checkpoints and highlights their applications in cancer immunotherapy.
A vial containing invitrogen vivofectamine delivery solutions next to a box.
Product News

Thermo Fisher Scientific Introduces Invitrogen™ Vivofectamine™ Delivery Solutions To Help Advance Life Science Research and Genetic Medicines

Thermo Fisher Scientific has introduced the Invitrogen Vivofectamine™ Delivery Solutions to provide high-performance lipid nanoparticles (LNP) technology for non-viral delivery of nucleic acids.
Double helix structure of DNA.
Product News

Tagomics Announces a Multiomic Profiling Co-Marketing Agreement With Agilent

Exclusive program will provide customers with a single, unified workflow for comprehensive genomic profiling and genome-wide epigenetic analysis.
Cancer cells.
Product News

Transgene and ProBioGen Join Forces To Advance Individualized Cancer Vaccine Development

Transgene and ProBioGen, announce that the companies have entered into a license agreement for ProBioGen’s AGE1.CR.pIX® suspension cell line.
Vaccine vial.
Product News

Transgene Provides Update on Phase II Trial of Therapeutic Cancer Vaccine TG4001 in Recurrent or Metastatic HPV16-Positive Cervical and Anogenital Cancers

Top line data show that the randomized Phase II study of TG4001 in combination with avelumab versus avelumab in patients with recurrent or metastatic HPV16-positive cervical and anogenital tumors did not meet the primary objective of improvement.
T cells.
Product News

Quell Therapeutics Expands Manufacturing Capabilities for CAR-Treg Cell Therapy Pipeline Through Partnership With eXmoor Pharma

Quell Therapeutics Ltd (“Quell” or “the Company”), and eXmoor pharma (“eXmoor”), announce a strategic partnership for the manufacture of multiple autologous engineered CAR-Treg cell therapies in Quell’s pipeline targeting autoimmune diseases.
Cell therapy.
Product News

Nona Biosciences Enters Into Collaboration Agreement With Umoja Biopharma To Advance In Vivo CAR-T Cell Therapies

Nona Biosciences, announced that it has entered into a multi-target antibody discovery collaboration with Umoja Biopharma. This collaboration leverages Nona's proprietary fully human heavy chain only antibody (HCAb) technology.
Advertisement